Australia markets closed

ZIVO Bioscience, Inc. (9R8.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
3.21000.0000 (0.00%)
At close: 08:12PM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

Currency in USD. All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
274.38
1,799
8,902
137.862
Total cash
274.38
1,799
8,902
137.862
Net receivables
3.735
0
-
-
Total current assets
425.377
1,902
8,960
167.815
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
98.28
189.282
27.225
149.364
Accumulated depreciation
-
-
-100
-100
Net property, plant and equipment
98.28
189.282
27.225
49.364
Total non-current assets
130.338
221.34
30.225
52.364
Total assets
555.715
2,123
8,990
220.179
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
240
240
240
5,189
Accounts payable
993.09
490.67
654.333
1,560
Accrued liabilities
100.686
98.286
95.886
2,465
Deferred revenues
-
-
-
1,937
Total current liabilities
2,762
2,028
2,948
11,394
Non-current liabilities
Long-term debt
-
-
-
121.7
Total non-current liabilities
0
105.919
0
136.878
Total liabilities
2,762
2,134
2,948
11,531
Stockholders' equity
Common stock
2.383
1.57
9.42
5.163
Retained earnings
-123,582
-115,805
-107,059
-99,064
Total stockholders' equity
-2,206
-10.622
6,042
-11,311
Total liabilities and stockholders' equity
555.715
2,123
8,990
220.179